FI45048B - - Google Patents

Info

Publication number
FI45048B
FI45048B FI3001/65A FI300165A FI45048B FI 45048 B FI45048 B FI 45048B FI 3001/65 A FI3001/65 A FI 3001/65A FI 300165 A FI300165 A FI 300165A FI 45048 B FI45048 B FI 45048B
Authority
FI
Finland
Application number
FI3001/65A
Other languages
Finnish (fi)
Other versions
FI45048C (fi
Inventor
M Matter
F Staehelin
Original Assignee
Haco Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haco Ag filed Critical Haco Ag
Publication of FI45048B publication Critical patent/FI45048B/fi
Application granted granted Critical
Publication of FI45048C publication Critical patent/FI45048C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Laminated Bodies (AREA)
  • Shaping By String And By Release Of Stress In Plastics And The Like (AREA)
FI653001A 1964-12-15 1965-12-14 Menetelmä analgeettisesti ja/tai tulehduksenvastaisesti vaikuttavien a ntraniilihappojohdannaisten valmistamiseksi. FI45048C (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1616164A CH451945A (de) 1964-12-15 1964-12-15 Verfahren zur Herstellung von neuen N-Pyrimidylanthranilsäuren

Publications (2)

Publication Number Publication Date
FI45048B true FI45048B (zh) 1971-11-30
FI45048C FI45048C (fi) 1972-03-10

Family

ID=4414930

Family Applications (1)

Application Number Title Priority Date Filing Date
FI653001A FI45048C (fi) 1964-12-15 1965-12-14 Menetelmä analgeettisesti ja/tai tulehduksenvastaisesti vaikuttavien a ntraniilihappojohdannaisten valmistamiseksi.

Country Status (14)

Country Link
US (1) US3361749A (zh)
AT (1) AT256854B (zh)
BE (1) BE673707A (zh)
BR (1) BR6575691D0 (zh)
CH (1) CH451945A (zh)
DE (1) DE1545978A1 (zh)
DK (1) DK117835B (zh)
ES (1) ES320729A1 (zh)
FI (1) FI45048C (zh)
FR (2) FR1469035A (zh)
GB (1) GB1132244A (zh)
IL (1) IL24797A (zh)
NL (2) NL6516326A (zh)
NO (1) NO117424B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH448083A (de) * 1963-05-04 1967-12-15 Ciba Geigy Verwendung von neuen Hydroxyaryl-pyrimidinen bei Verfahren zum Schützen von nicht-textilen organischen Materialien
CA2406562C (en) * 2000-05-08 2009-09-15 Janssen Pharmaceutica N.V. Hiv replication inhibiting pyrimidines and triazines
GB0206215D0 (en) * 2002-03-15 2002-05-01 Novartis Ag Organic compounds
GB0305929D0 (en) * 2003-03-14 2003-04-23 Novartis Ag Organic compounds
EP2287156B1 (en) 2003-08-15 2013-05-29 Novartis AG 2,4-Di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
WO2007048064A2 (en) * 2005-10-21 2007-04-26 Exelixis, Inc. Amino-pyrimidines as casein kinase ii (ck2) modulators
ES2559528T3 (es) 2006-12-08 2016-02-12 Novartis Ag Compuestos y composiciones como inhibidores de proteína cinasa
LU92852B1 (en) * 2015-10-20 2017-05-02 Athanasios Spathis NURR1:RXR activating compounds for simultaneous treatment of symptoms and pathology of Parkinsons disease

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB971307A (en) * 1961-03-02 1964-09-30 Wellcome Found 5-anilinopyrimidines

Also Published As

Publication number Publication date
BE673707A (zh) 1966-04-01
FR5213M (zh) 1967-07-03
NL129020C (zh)
ES320729A1 (es) 1966-05-16
CH451945A (de) 1968-05-15
DK117835B (da) 1970-06-08
GB1132244A (en) 1968-10-30
NL6516326A (zh) 1966-06-16
BR6575691D0 (pt) 1973-09-06
AT256854B (de) 1967-09-11
IL24797A (en) 1969-11-12
US3361749A (en) 1968-01-02
FI45048C (fi) 1972-03-10
DE1545978A1 (de) 1969-12-11
FR1469035A (fr) 1967-02-10
NO117424B (zh) 1969-08-11

Similar Documents

Publication Publication Date Title
FI45048B (zh)
BE642395A (zh)
BE564626A (zh)
BE642367A (zh)
BE642316A (zh)
BE660988A (zh)
BE642243A (zh)
BE642212A (zh)
BE642114A (zh)
BE642104A (zh)
BE637950A (zh)
BE660671A (zh)
BE660324A (zh)
BE660193A (zh)
BE660181A (zh)
BE637777A (zh)
BE659988A (zh)
BE637333A (zh)
BE659649A (zh)
BE636791A (zh)
BE658859A (zh)
BE658849A (zh)
BE47396A (zh)
BE658221A (zh)
BE658057A (zh)